April 23, 2013 / 8:11 PM / 4 years ago

Amgen first-quarter profit, revenue rise

April 23 (Reuters) - Amgen Inc on Tuesday reported higher first-quarter profit on increased sales of its drug Enbrel for rheumatoid arthritis and newer medicines to help prevent bone fractures.

The world's largest biotechnology company posted a net profit of $1.43 billion, or $1.88 per share, compared with a profit of $1.18 billion, or $1.48 per share, a year ago.

Excluding one time items, Amgen had adjusted earnings of $1.96. Analysts on average expected $1.84 per share, according to Thomson Reuters I/B/E/S.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below